Mint-Betahistine recall in Canada: Incorrect dosing
In plain language
This recall involves Mint-Betahistine 8, 16, and 24mg tablets sold in Canada. It's being recalled because of concerns with the product's bioequivalence data, which could lead to incorrect dosing. Stop using the product and follow the return/repair steps in the official notice.
What to do
- Stop using the product immediately.
- Return it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Mint-Betahistine 8mg
Mint-Betahistine 16mg
Mint-Betahistine 24mg
Why this matters
Incorrect dosing
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Incorrect dosing
What should consumers do?
Stop using the product immediately. Return it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Incorrect dosing
When was this product recalled?
This product was recalled on June 6, 2024.
Is the Mint-Betahistine brand affected by this recall?
Yes, Mint-Betahistine products are affected by this recall. This recall involves Mint-Betahistine 8, 16, and 24mg tablets sold in Canada. It's being recalled because of concerns with the product's bioequivalence data, which could lead to incorrect dosing. Stop using the product and follow the return/repair steps in the official notice.